Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Nartey EN"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells.
Autor: Picco G; Wellcome Sanger Institute, Cambridge, UK., Rao Y; GSK, Upper Providence, Pennsylvania., Al Saedi A; Wellcome Sanger Institute, Cambridge, UK., Lee Y; GSK, Upper Providence, Pennsylvania., Vieira SF; Wellcome Sanger Institute, Cambridge, UK., Bhosle S; Wellcome Sanger Institute, Cambridge, UK., May K; Epigenetics Programme, Babraham Institute, Cambridge, UK., Herranz-Ors C; Wellcome Sanger Institute, Cambridge, UK., Walker SJ; Wellcome Sanger Institute, Cambridge, UK., Shenje R; GSK, Upper Providence, Pennsylvania., Dincer C; Wellcome Sanger Institute, Cambridge, UK., Gibson F; Wellcome Sanger Institute, Cambridge, UK., Banerjee R; Wellcome Sanger Institute, Cambridge, UK., Hewitson Z; Wellcome Sanger Institute, Cambridge, UK., Werner T; GSK Heidelberg, Germany., Cottom JE; GSK, Upper Providence, Pennsylvania., Peng Y; GSK, Upper Providence, Pennsylvania., Deng N; GSK, Cambridge, Massachusetts., Zhang Y; GSK, Upper Providence, Pennsylvania., Nartey EN; GSK, Upper Providence, Pennsylvania., Nickels L; GSK, Upper Providence, Pennsylvania., Landis P; GSK, Upper Providence, Pennsylvania., Conticelli D; Candiolo Cancer Institute, Turin, Italy., McCarten K; Wellcome Sanger Institute, Cambridge, UK., Bush J; GSK, Stevenage, UK., Sharma M; Wellcome Sanger Institute, Cambridge, UK., Lightfoot H; Wellcome Sanger Institute, Cambridge, UK., House D; GSK, Stevenage, UK., Milford E; GSK, Stevenage, UK., Grant EK; GSK, Stevenage, UK., Glogowski MP; GSK, Upper Providence, Pennsylvania., Wagner CD; GSK, Upper Providence, Pennsylvania., Bantscheff M; GSK Heidelberg, Germany., Rutkowska-Klute A; GSK Heidelberg, Germany., Zappacosta F; GSK, Upper Providence, Pennsylvania., Pettinger J; GSK, Stevenage, UK., Barthorpe S; Wellcome Sanger Institute, Cambridge, UK., Eberl HC; GSK Heidelberg, Germany., Jones BT; IDEAYA Biosciences, South San Francisco, California., Schneck JL; GSK, Upper Providence, Pennsylvania., Murphy DJ; GSK, Upper Providence, Pennsylvania., Voest EE; Netherlands Cancer Institute, Amsterdam, the Netherlands., Taygerly JP; IDEAYA Biosciences, South San Francisco, California., DeMartino MP; GSK, Upper Providence, Pennsylvania., Coelho MA; Wellcome Sanger Institute, Cambridge, UK., Houseley J; Epigenetics Programme, Babraham Institute, Cambridge, UK., Sharma G; GSK, Cambridge, Massachusetts., Schwartz B; GSK, Cambridge, Massachusetts., Garnett MJ; Wellcome Sanger Institute, Cambridge, UK.
Publikováno v: Cancer discovery [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1457-1475.
Zobrazit plný text záznamu
3
Akademický článek
Assessment of average glandular dose in mammography practice of a teaching hospital in Ghana.
Autor: Kyei KA; Department of Radiography, University of Ghana, Korle Bu, Accra, Ghana.; National Radiotherapy Oncology and Nuclear Medicine Centre, Korle Bu Teaching Hospital, Accra, Ghana., Anim-Sampong S; Department of Radiography, University of Ghana, Korle Bu, Accra, Ghana., Ahulu EN; Department of Radiography, University of Ghana, Korle Bu, Accra, Ghana., Antwi WK; Department of Radiography, University of Ghana, Korle Bu, Accra, Ghana., Daniels J; National Radiotherapy Oncology and Nuclear Medicine Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Publikováno v: The Pan African medical journal [Pan Afr Med J] 2024 Feb 02; Vol. 47, pp. 42. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells.
Autor: Di Marco CN; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA. Electronic address: christina.n.di-marco@gsk.com., Terrell L; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Sanchez R; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Rueda L; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Shuster L; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Nartey EN; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., McHugh C; Drug Metabolism and Pharmacokinetics, Research In Vivo/In Vitro Translation, GSK, Collegeville, PA 19426, USA., Mack JF; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Shu A; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Tian X; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Medina JR; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Rivero R; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Manetsch R; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA; Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA; Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, MA 02115, USA., Heerding D; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA., Mangatt B; Medicinal Science and Technology, GSK, Collegeville, PA 19426, USA.
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Aug 15; Vol. 92, pp. 129385. Date of Electronic Publication: 2023 Jun 18.
Zobrazit plný text záznamu
5
Akademický článek
Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce c -MYC Protein Levels in Cells.
Autor: Medina JR; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Tian X; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Li WH; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Suarez D; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Mack JF; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., LaFrance L; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Martyr C; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Brackley J; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Di Marco C; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Rivero R; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Heerding DA; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., McHugh C; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Minthorn E; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Bhaskar A; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Rubin J; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Butticello M; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Carpenter C; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Nartey EN; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Berrodin TJ; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Kallal LA; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Mangatt B; Oncology Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2021 Nov 11; Vol. 64 (21), pp. 16056-16087. Date of Electronic Publication: 2021 Oct 20.
Zobrazit plný text záznamu
6
Akademický článek
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1.
Autor: Anderson K; Enzymology & Mechanistic Pharmacology, GlaxoSmithKline, Collegeville, PA 19426, USA., Lai Z, McDonald OB, Stuart JD, Nartey EN, Hardwicke MA, Newlander K, Dhanak D, Adams J, Patrick D, Copeland RA, Tummino PJ, Yang J
Publikováno v: The Biochemical journal [Biochem J] 2009 May 13; Vol. 420 (2), pp. 259-65. Date of Electronic Publication: 2009 May 13.
Zobrazit plný text záznamu
7
Akademický článek
Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2.
Autor: Miyazaki Y; GlaxoSmithKline, Tsukuba Research Laboratories, 43, Wadai, Tsukuba 300-4247, Ibaraki, Japan. yasushi.miyazaki@gsk.com, Tang J, Maeda Y, Nakano M, Wang L, Nolte RT, Sato H, Sugai M, Okamoto Y, Truesdale AT, Hassler DF, Nartey EN, Patrick DR, Ho ML, Ozawa K
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2007 Mar 15; Vol. 17 (6), pp. 1773-8. Date of Electronic Publication: 2006 Dec 24.
Zobrazit plný text záznamu
8
Akademický článek
Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.
Autor: Miyazaki Y; GlaxoSmithKline K.K., Tsukuba Research Laboratories, 43, Wadai, Tsukuba 300-4247, Ibaraki, Japan. yasushi.miyazaki@gsk.com, Nakano M, Sato H, Truesdale AT, Stuart JD, Nartey EN, Hightower KE, Kane-Carson L
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2007 Jan 01; Vol. 17 (1), pp. 250-4. Date of Electronic Publication: 2006 Oct 05.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje